2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)

European Heart Journal, Journal Year: 2020, Volume and Issue: 42(5), P. 373 - 498

Published: July 17, 2020

Supplementary Table 9, column 'Edoxaban', row 'eGFR category', '95 mL/min' (page 15). The cell should be coloured green instead of yellow. It also read 60 mginstead mg (use with caution in 'supranormal' renal function).In the above-indicated cell, a footnote has been added to state: Edoxaban used patients high creatinine clearance only after careful evaluation individual thromboembolic and bleeding risk.Supplementary 'Dose reduction selected patients' 16). reduced 30 once daily if any following: 15-50 mL/min, body weight <60 kg, concomitant use dronedarone, erythromycin, ciclosporine or ketokonazoleinstead daily, edoxaban 15mg 30-50 us verapamil quinidine dronedarone.

Language: Английский

---

2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes

European Heart Journal, Journal Year: 2019, Volume and Issue: 41(3), P. 407 - 477

Published: Aug. 31, 2019

Coronary artery disease (CAD) is a pathological process characterized by atherosclerotic plaque accumulation in the epicardial arteries, whether obstructive or non-obstructive. This can be modified lifestyle adjustments, pharmacological therapies, and invasive interventions designed to achieve stabilization regression. The have long, stable periods but also become unstable at any time, typically due an acute atherothrombotic event caused rupture erosion. However, chronic, most often progressive, hence serious, even clinically apparently silent periods. dynamic nature of CAD results various clinical presentations, which conveniently categorized as either coronary syndromes (ACS) chronic (CCS). Guidelines presented here refer management patients with CCS. natural history CCS illustrated Figure 1.

Language: Английский

---

2021 ESC Guidelines on cardiovascular disease prevention in clinical practice

European Heart Journal, Journal Year: 2021, Volume and Issue: 42(34), P. 3227 - 3337

Published: Aug. 30, 2021

The ESC Guidelines represent the views of and were produced after careful consideration scientific medical knowledge evidence available at time their publication.The is not responsible in event any contradiction, discrepancy and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals are encouraged take fully into account when exercising clinical judgment, as well determination implementation preventive, diagnostic strategies; however, do override, way whatsoever, individual responsibility make appropriate accurate decisions each patient's condition consultation with that patient and, where necessary, caregiver.Nor exempt from taking full updated competent order manage case light scientifically accepted data pursuant respective ethical professional obligations.It also professional's verify applicable rules regulations relating drugs devices prescription.

Language: Английский

---

2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation

European Heart Journal, Journal Year: 2020, Volume and Issue: 42(14), P. 1289 - 1367

Published: July 10, 2020

A correction has been published: European Heart Journal, ehaa895, https://doi.org/10.1093/eurheartj/ehaa895

Language: Английский

---

2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

European Heart Journal, Journal Year: 2019, Volume and Issue: 41(2), P. 255 - 323

Published: Aug. 31, 2019

The Guidelines represent the views of ESC and were produced after careful consideration scientific medical knowledge, evidence available at time their publication.The EASD are not responsible in event any contradiction, discrepancy, and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals encouraged take fully into account when exercising clinical judgment, as well determination implementation preventive, diagnostic, strategies; however, do override, way whatsoever, individual responsibility make appropriate accurate decisions each patient's condition consultation with that patient and, where necessary, caregiver.Nor exempt from taking full updated competent order manage case light scientifically accepted data pursuant respective ethical professional obligations.It is also professional's verify applicable rules regulations relating drugs devices prescription.

Language: Английский

---

2021 ESC/EACTS Guidelines for the management of valvular heart disease

European Heart Journal, Journal Year: 2021, Volume and Issue: 43(7), P. 561 - 632

Published: June 11, 2021

Guidelines •

Language: Английский

---

2023 ESC Guidelines for the management of acute coronary syndromes

European Heart Journal, Journal Year: 2023, Volume and Issue: 44(38), P. 3720 - 3826

Published: Aug. 25, 2023

Language: Английский

---

2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease

European Heart Journal, Journal Year: 2020, Volume and Issue: 42(1), P. 17 - 96

Published: July 10, 2020

The ESC Guidelines represent the views of and were produced after careful consideration scientific medical knowledge evidence available at time their publication.The is not responsible in event any contradiction, discrepancy and/or ambiguity between other official recommendations or guidelines issued by relevant public health authorities, particular relation to good use healthcare therapeutic strategies.Health professionals are encouraged take fully into account when exercising clinical judgment, as well determination implementation preventive, diagnostic strategies; however, do override, way whatsoever, individual responsibility make appropriate accurate decisions each patient's condition consultation with that patient and, where necessary, caregiver.Nor exempt from taking full updated competent order manage case light scientifically accepted data pursuant respective ethical professional obligations.It also professional's verify applicable rules regulations relating drugs devices prescription.

Language: Английский

---

2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization

Journal of the American College of Cardiology, Journal Year: 2021, Volume and Issue: 79(2), P. e21 - e129

Published: Dec. 9, 2021

Language: Английский

---

Reduction of hospitalizations for myocardial infarction in Italy in the COVID-19 era

European Heart Journal, Journal Year: 2020, Volume and Issue: 41(22), P. 2083 - 2088

Published: April 29, 2020

Abstract Aims To evaluate the impact of COVID-19 pandemic on patient admissions to Italian cardiac care units (CCUs). Methods and Results We conducted a multicentre, observational, nationwide survey collect data for acute myocardial infarction (AMI) at CCUs throughout 1 week period during outbreak, compared with equivalent in 2019. observed 48.4% reduction AMI 2019 (P &lt; 0.001). The was significant both ST-segment elevation [STEMI; 26.5%, 95% confidence interval (CI) 21.7–32.3; P = 0.009] non-STEMI (NSTEMI; 65.1%, CI 60.3–70.3; Among STEMIs, higher women (41.2%; 0.011) than men (17.8%; 0.191). A similar registered North Italy (52.1%), Central (59.3%), South (52.1%). STEMI case fatality rate substantially increased [risk ratio (RR) 3.3, 1.7–6.6; 0.001]. parallel increase complications also (RR 1.8, 1.1–2.8; 0.009). Conclusion Admissions were significantly reduced across Italy, complication rates. This constitutes serious social issue, demanding attention by scientific healthcare communities public regulatory agencies.

Language: Английский

---